Acurx Pharmaceuticals, Inc. (ACXP)
NASDAQ: ACXP · Real-Time Price · USD
1.840
-0.090 (-4.66%)
Jun 2, 2026, 11:22 AM EDT - Market open
Acurx Pharmaceuticals Market Cap
Acurx Pharmaceuticals has a market cap or net worth of $6.75 million as of June 2, 2026. Its market cap has decreased by -22.90% in one year.
Market Cap
6.75M
Enterprise Value
-2.46M
1-Year Change
-22.90%
Ranking
Category
Stock Price
$1.84
Market Cap Chart
Since the IPO on June 25, 2021, Acurx Pharmaceuticals's market cap has decreased from $57.25M to $6.75M, a decrease of -88.20%. That is a compound annual growth rate of -35.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 1, 2026 | 7.09M | 21.18% |
| Dec 31, 2025 | 5.85M | -57.48% |
| Dec 31, 2024 | 13.75M | -73.92% |
| Dec 29, 2023 | 52.73M | 14.29% |
| Dec 30, 2022 | 46.14M | 4.51% |
| Dec 31, 2021 | 44.15M | -22.88% |
| Jun 25, 2021 | 57.25M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PMGC Holdings | 8.04M |
| Genprex | 7.94M |
| Xenetic Biosciences | 7.58M |
| CNS Pharmaceuticals | 7.35M |
| Evogene | 7.34M |
| Can-Fite BioPharma | 6.99M |
| Alaunos Therapeutics | 6.95M |
| Processa Pharmaceuticals | 6.73M |